Abstract
Purpose
Although multiple myeloma (MM) is incurable, many people live with the disease for a number of years. Thus, understanding the effect of the disease and its therapies on the lives of those with MM is important. This qualitative study explores the impact of MM and its treatments on patients.
Methods
People with newly diagnosed or relapsed MM were recruited from a tertiary institution. Participants were interviewed using a semi-structured approach. The questions were designed to obtain insight into how participants viewed their diagnosis, treatment, and symptoms and how these had impacted on their lives. Data were analysed using a phenomenological approach.
Results
Fifteen people with MM with a mean age of 62 were recruited. Participants’ mean time since diagnosis was 2.7 years and they had received a mean of 1.7 lines of therapy. The first major theme to emerge was lifestyle changes. Interviewees described MM as causing changes to all aspects of their lives, including substantial functional changes, as well as changes to employment, relationships, and their sense of self. The second major theme was ‘adjust, adjust, adjust’. Alongside challenging life changes, participants described a range of practical, psychological, and relational approaches to adjusting to living with MM.
Conclusion
This study highlights the importance of and the need for improved supportive care in patients with MM, ideally with a multidisciplinary approach. It also identifies the potential for further investigation of patient approaches to adjusting to MM and development of support strategies.
Similar content being viewed by others
References
Australian Institue of Health and Welfare Myeloma in Australia. https://myeloma-cancer.canceraustralia.gov.au/statistics. Accessed 12 Oct 2017
Cancer Institute of NSW Multiple myeloma. https://www.cancerinstitute.org.au/understanding-cancer/cancer-in-nsw/multiple-myeloma. Accessed 12 Oct 2017
Pozzi S, Marcheselli L, Bari A, Liardo EV, Marcheselli R, Luminari S, Quaresima M, Cirilli C, Ferri P, Federico M, Sacchi S (2013) Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis. Br J Haematol 163:40–46. https://doi.org/10.1111/bjh.12465
Fadul NA, Osta BE, Dalal S, Poulter VA, Bruera E (2008) Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 11:422–427. https://doi.org/10.1089/jpm.2007.0184
Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, Petrucci MT (2013) Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia 27:1959–1969. https://doi.org/10.1038/leu.2013.185
LeBlanc TW, Abernethy AP, Casarett DJ (2015) What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manag 49:505–512. https://doi.org/10.1016/j.jpainsymman.2014.07.003
Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J (2011) The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manag 42:432–442. https://doi.org/10.1016/j.jpainsymman.2010.12.008
Baz R, Lin HM, Hui A-M, Harvey RD, Colson K, Gallop K, Swinburn P, Laubach J, Berg D, Richardson P (2015) Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life. Support Care Cancer 23:2789–2797. https://doi.org/10.1007/s00520-015-2644-6
Osborne TR, Ramsenthaler C, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2012) What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. Eur J Haematol 89:437–457. https://doi.org/10.1111/ejh.12012
Meyer J (2000) Using qualitative methods in health related action research. Br Med J 320:178–181
Sloot S, Boland J, Snowden JA, Ezaydi Y, Foster A, Gethin A, Green T, Chopra L, Verhagen S, Vissers K, Engels Y, Ahmedzai SH (2015) Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study. Support Care Cancer 23:671–678. https://doi.org/10.1007/s00520-014-2358-1
Mortensen GL, Salomo M (2016) Quality of life in patients with multiple myeloma: a qualitative study. J Cancer Sci Ther 8. https://doi.org/10.4172/1948-5956.1000430
Pope C, Ziebland S, Mays N (2000) Analysing qualitative data. Br Med J 320:114–116
Potrata B, Cavet J, Blair S, Howe T, Molassiotis A (2011) Understanding distress and distressing experiences in patients living with multiple myeloma: an exploratory study. Psychooncology 20:127–134. https://doi.org/10.1002/pon.1715
Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89:311–319. https://doi.org/10.1111/j.1600-0609.2012.01831.x
Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology 20:88–97. https://doi.org/10.1002/pon.1710
Jones D, Vichaya EG, Wang XS, Williams LA, Shah ND, Thomas SK, Johnson VE, Champlin RE, Cleeland CS, Mendoza TR (2013) Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol 6:13. https://doi.org/10.1186/1756-8722-6-13
Zabora J, Buzaglo J, Kennedy V, Richards T, Schapmire T, Zebrack B, Ghobrial IM (2015) Clinical perspective: linking psychosocial care to the disease continuum in patients with multiple myeloma. Palliat Support Care 13:829–838. https://doi.org/10.1017/S1478951514000649
Palumbo A, Bringhen S, Mateos M-V, Larocca A, Facon T, Kumar SK, Offidani M, McCarthy P, Evangelista A, Lonial S, Zweegman S, Musto P, Terpos E, Belch A, Hajek R, Ludwig H, Stewart AK, Moreau P, Anderson K, Einsele H, Durie BGM, Dimopoulos MA, Landgren O, San Miguel JF, Richardson P, Sonneveld P, Rajkumar SV (2015) Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood 125:2068–2074
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med 363:733–742
Stewart DE, Yuen T (2011) A systematic review of resilience in the physically ill. Psychosomatics 52:199–209. https://doi.org/10.1016/j.psym.2011.01.036
Min J-A, Yoon S, Lee C-U, Chae JH, Lee C, Song KY, Kim TS (2013) Psychological resilience contributes to low emotional distress in cancer patients. Support Care Cancer Off J Multinatl Assoc. Support Care Cancer 21:2469–2476 . doi: https://doi.org/10.1007/s00520-013-1807-6
Duijts SFA, Faber MM, Oldenburg HSA, van Beurden M, Aaronson NK (2011) Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors--a meta-analysis. Psychooncology 20:115–126. https://doi.org/10.1002/pon.1728
Felder BE (2004) Hope and coping in patients with cancer diagnoses. Cancer Nurs 27:320–324
Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S (1995) Ethnicity and attitudes toward patient autonomy. JAMA 274:820–825. https://doi.org/10.1001/jama.1995.03530100060035
Funding
The Western Australian Cancer and Palliative Care Network provided funding for Dr. Rosslyn de Wet’s fellowship to perform this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Rosslyn de Wet was awarded a 1-year fellowship by the WA Cancer and Palliative Care Network.
Dr Rosslyn de Wet has full control of the primary data which is available for review.
Rights and permissions
About this article
Cite this article
de Wet, R., Lane, H., Tandon, A. et al. ‘It is a journey of discovery’: living with myeloma. Support Care Cancer 27, 2435–2442 (2019). https://doi.org/10.1007/s00520-018-4502-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4502-9